Litcius/Paper detail

An Integrated Systems Biology Approach Identifies the Proteasome as a Critical Host Machinery for ZIKV and DENV Replication

Guang Song, Emily M. Lee, Jianbo Pan, Miao Xu, Hee‐Sool Rho, Yichen Cheng, Nadia Whitt, Shu Yang, Jennifer Kouznetsova, Carleen Klumpp‐Thomas, Sam Michael, Cedric Moore, Ki‐Jun Yoon, Kimberly M. Christian, Anton Simeonov, Wenwei Huang, Menghang Xia, Ruili Huang, Madhu Lal‐Nag, Hengli Tang, Wei Zheng, Jiang Qian, Hongjun Song, Guo‐li Ming, Heng Zhu

2021Genomics Proteomics & Bioinformatics12 citationsDOIOpen Access PDF

Abstract

The Zika virus (ZIKV) and dengue virus (DENV) flaviviruses exhibit similar replicative processes but have distinct clinical outcomes. A systematic understanding of virus-host protein-protein interaction networks can reveal cellular pathways critical to viral replication and disease pathogenesis. Here we employed three independent systems biology approaches toward this goal. First, protein array analysis of direct interactions between individual ZIKV/DENV viral proteins and 20,240 human proteins revealed multiple conserved cellular pathways and protein complexes, including proteasome complexes. Second, an RNAi screen of 10,415 druggable genes identified the host proteins required for ZIKV infection and uncovered that proteasome proteins were crucial in this process. Third, high-throughput screening of 6016 bioactive compounds for ZIKV inhibition yielded 134 effective compounds, including six proteasome inhibitors that suppress both ZIKV and DENV replication. Integrative analyses of these orthogonal datasets pinpoint proteasomes as critical host machinery for ZIKV/DENV replication. Our study provides multi-omics datasets for further studies of flavivirus-host interactions, disease pathogenesis, and new drug targets.

Topics & Concepts

Host (biology)BiologyReplication (statistics)Computational biologyVirologySystems biologyEvolutionary biologyGeneticsMosquito-borne diseases and controlCytomegalovirus and herpesvirus researchUbiquitin and proteasome pathways